Tiemann Investment Advisors’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$242K	Hold	3,500	–	–	0.1%	164
2025 Q1	$243K	Sell	3,500 -250	-7%	-$17.4K	0.11%	159
2024 Q4	$323K	Hold	3,750	–	–	0.14%	123
2024 Q3	$447K	Sell	3,750 -300	-7%	-$35.7K	0.19%	102
2024 Q2	$578K	Hold	4,050	–	–	0.26%	78
2024 Q1	$520K	Hold	4,050	–	–	0.23%	92
2023 Q4	$419K	Hold	4,050	–	–	0.2%	102
2023 Q3	$368K	Hold	4,050	–	–	0.2%	109
2023 Q2	$328K	Hold	4,050	–	–	0.17%	129
2023 Q1	$322K	Hold	4,050	–	–	0.18%	128
2022 Q4	$274K	Hold	4,050	–	–	0.16%	147
2022 Q3	$202K	Hold	4,050	–	–	0.13%	171
2022 Q2	$226K	Hold	4,050	–	–	0.12%	166
2022 Q1	$225K	Sell	4,050 -1,500	-27%	-$83.3K	0.1%	186
2021 Q4	$311K	Hold	5,550	–	–	0.13%	162
2021 Q3	$266K	Hold	5,550	–	–	0.13%	164
2021 Q2	$232K	Buy	+5,550	New	+$232K	0.11%	191
2016 Q4	–	Sell	-14,000	Closed	-$291K	–	165
2016 Q3	$291K	Hold	14,000	–	–	0.27%	119
2016 Q2	$376K	Buy	14,000 +2,500	+22%	+$67.1K	0.35%	92
2016 Q1	$312K	Hold	11,500	–	–	0.31%	107
2015 Q4	$334K	Hold	11,500	–	–	0.34%	91
2015 Q3	$312K	Buy	11,500 +800	+7%	+$21.7K	0.34%	96
2015 Q2	$293K	Hold	10,700	–	–	0.3%	111
2015 Q1	$286K	Buy	10,700 +600	+6%	+$16K	0.3%	109
2014 Q4	$214K	Hold	10,100	–	–	0.23%	132
2014 Q3	$240K	Buy	10,100 +200	+2%	+$4.75K	0.27%	119
2014 Q2	$229K	Buy	9,900 +400	+4%	+$9.25K	0.25%	126
2014 Q1	$217K	Buy	+9,500	New	+$217K	0.24%	135